Project

Trp-IBD: Tryptophan for persistent fatigue in quiescent Inflammatory Bowel Disease: a double-blind placebo-controlled clinical trial

Acronym
Trp-IBD
Code
3179P6717
Duration
01 October 2017 → 30 September 2020
Funding
Research Foundation - Flanders (FWO)
Research disciplines
  • Medical and health sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other basic sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other clinical sciences
    • Other health sciences
    • Nursing
    • Other paramedical sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other translational sciences
    • Other medical and health sciences
Keywords
bowel disease
 
Project description

The end use of this project proposal is to provide evidence for the attribution of a therapeutic property to the dietary supplement tryptophan (Trp) for pathological fatigue in patients with inflammatory bowel disease (IBD) in remission. It offers gastroenterologists and general practitioners the opportunity to treat this persistent complaint in their patient population, through a means that is widely available and safe.